TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 73 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21 | -19.2% | 564 | -17.5% | 0.00% | -100.0% |
| Q2 2023 | $26 | -10.3% | 684 | -42.2% | 0.00% | 0.0% |
| Q1 2023 | $29 | +45.0% | 1,184 | +73.4% | 0.00% | – |
| Q4 2022 | $20 | -99.9% | 683 | -6.8% | 0.00% | -100.0% |
| Q3 2022 | $21,000 | -25.0% | 733 | -6.3% | 0.00% | 0.0% |
| Q2 2022 | $28,000 | -22.2% | 782 | -5.4% | 0.00% | 0.0% |
| Q1 2022 | $36,000 | -20.0% | 827 | -7.7% | 0.00% | 0.0% |
| Q4 2021 | $45,000 | – | 896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 545,583 | $34,715,000 | 10.89% |
| Murchinson Ltd. | 100,000 | $6,363,000 | 3.16% |
| Eversept Partners, LP | 179,366 | $11,413,059 | 0.79% |
| BRANDES INVESTMENT PARTNERS, LP | 266,560 | $16,962,000 | 0.37% |
| Analyst IMS Investment Management Services Ltd. | 22,755 | $1,447,000 | 0.18% |
| Claret Asset Management Corp | 9,336 | $594,000 | 0.10% |
| ACADIAN ASSET MANAGEMENT LLC | 344,023 | $21,851,000 | 0.08% |
| Renaissance Technologies | 720,500 | $45,845,000 | 0.06% |
| C M BIDWELL & ASSOCIATES LTD | 1,155 | $73,000 | 0.05% |
| First Trust Direct Indexing L.P. | 3,357 | $214,000 | 0.03% |